Basic Information
| LncRNA/CircRNA Name | HANR |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qRT-PCR |
| Sample | NSCLC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | LncRNA HANR accelerates the proliferative, migratory and invasive abilities of NSCLC via negatively mediating miRNA-140-5p. Furthermore, HANR is closely correlated with lymphatic metastasis, distant metastasis and poor prognosis of NSCLC. |
| Pubmed ID | 32016972 |
| Year | 2020 |
| Title | LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p |
External Links
| Links for HANR | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |